2006
DOI: 10.4049/jimmunol.176.9.5616
|View full text |Cite
|
Sign up to set email alerts
|

Adenosine A2A Receptor Inactivation Increases Survival in Polymicrobial Sepsis

Abstract: The mechanisms governing the impairment of bacterial clearance and immune function in sepsis are not known. Adenosine levels are elevated during tissue hypoxia and damage associated with sepsis. Adenosine has strong immunosuppressive effects, many of which are mediated by A2A receptors (A2AR) expressed on immune cells. We examined whether A2AR are involved in the regulation of immune function in cecal ligation and puncture-induced murine polymicrobial sepsis by genetically or pharmacologically inactivating A2A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
119
4
1

Year Published

2007
2007
2016
2016

Publication Types

Select...
4
3
1

Relationship

2
6

Authors

Journals

citations
Cited by 120 publications
(130 citation statements)
references
References 76 publications
6
119
4
1
Order By: Relevance
“…These include HMBG-1, A 2A and C5a. [34][35][36] Our results confirm that MIF is also a promising target for the treatment of sepsis. We also show that MIF/TTX DNA vaccination may provide a new strategy for the prevention and management of sepsis.…”
Section: Mif/ttx Dna Vaccination and Sepsis S Tohyama Et Alsupporting
confidence: 75%
“…These include HMBG-1, A 2A and C5a. [34][35][36] Our results confirm that MIF is also a promising target for the treatment of sepsis. We also show that MIF/TTX DNA vaccination may provide a new strategy for the prevention and management of sepsis.…”
Section: Mif/ttx Dna Vaccination and Sepsis S Tohyama Et Alsupporting
confidence: 75%
“…On the other hand, adenosine receptor ligands that have the ability to facilitate the inflammatory/ immune responses of macrophages represent potential therapies for infectious diseases. A good example for this notion is our recent observation that A 2A receptor blockade can promote antibacterial immunity and bacterial clearance in septic animals (Nemeth et al, 2006). Finally, there is convincing evidence that selective adenosine receptor antagonists (A 2B and A 3 ) are potential therapeutics for asthma and chronic lung disease (Fozard & Hannon, 1999;Fozard & McCarthy, 2002;Blackburn, 2003;Fozard, 2003;Mohsenin & Blackburn, 2006;Spicuzza et al, 2006).…”
Section: Therapeutic Implicationsmentioning
confidence: 99%
“…Receptor deletion fails to modify inflammatory markers/injury in some studies [22], reportedly worsens endotoxemic injury in heart [23] and lung [15,24] and improves survival in models of polymicrobial sepsis [25,26]. These divergent outcomes may reflect different cell-and organ-specific effects of A 2A Rs, for example promoting inflammasome formation and macrophage-dependent injury [27], impairing bacterial clearance [25], while activating cardiac survival signalling and suppressing inflammation [3,7,[12][13][14]. Nonetheless, opposing effects of endogenous vs. exogenous (or amplified endogenous) adenosine are evident within cell types, for example inhibiting vs. promoting vascular myocyte NOS activation with inflammation [28].…”
Section: J Ashton and Melissa E Reichelt Denotes Equal First Authormentioning
confidence: 99%